In September 2026 the Australian Parliament announced a new Senate Inquiry into Australian blood and blood products infected with bloodborne viruses (hepatitis B, hepatitis C/HCV and HIV) during the 1970s–1990s.
What does this mean for the bleeding disorders community? You may have questions about how the inquiry process works and what it might mean for you.
We know this development may bring up strong emotions for many of our community members. Part of this may be the uncertainty – hoping for better outcomes at last, but aware that none of us can know what the outcomes of this Inquiry will be. Our community has proven its resilience over the years and this may be the time that some community members wish to make the Senate Committee and the wider community aware of their experiences.
In this web hub we’ll provide key information on the inquiry, explain HFA’s advocacy priorities, and share details on how to get involved if you wish to participate.
Due to the sensitive nature of this topic and how it affects our community members, HFA has chosen to limit social media posts and will primarily communicate our regular updates via email and the HFA website.
For over 30 years HFA has stood alongside our community in advocating for recognition, care, and justice regarding infected blood products. We remain firmly committed to supporting you through every step of this Senate Inquiry process.